Transport of IRW， an ovotransferrin-derived antihypertensive peptide， in human intestinal epithelial Caco-2 cells.

IRW is an egg ovotransferrin-derived ACE inhibitory peptide. The purpose of this study was to evaluate the stability and transcellular transport of IRW in Caco-2 cell monolayers. The stability of IRW was monitored on the apical (AP) surface while its transport was studied from AP to basal (BL) and from BL to AP surfaces. The results revealed that IRW is resistant against intestinal peptidase up to 60 min. Transport of IRW was not affected by addition of wortamanin， a transcytosis inhibitor. However， in the presence of cytochalasin D， a gap junction disruptor， transport of IRW was significantly increased， suggesting a possible passive transport from AP to BL surface. A higher transport of IRW from AP to BL surface than that from BL to AP surface suggests a passive-mediated transport. Moreover， in the presence of glycyl-sarcosine， a substrate for peptide transporter PepT 1， transport of IRW was reduced from AP to BL surface. The above observations showed atypical transport of IRW in Caco-2 cell monolayers. Thus， IRW may possibly be absorbed intact into the site of action for controlling hypertension.